Skip to main content

Tilray Brands, Inc. (TLRY)

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Last price
$2.35
As of

Kresmion compiles this page from TLRY's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Tilray Brands, Inc. (TLRY): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-10-08.

As of . Source: SEC EDGAR filings for TLRY. Method and limitations.

COMPANY DOSSIER

See the full TLRY dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for TLRY on one page. Preview it with sample data, then open it live with a free account.

Preview the TLRY dossier

Active events for TLRY

  • lowEarnings below estimates

    Q4-2026: EPS $-0.43 vs $-0.0136 estimate, -0.42 on a near-zero consensus

  • lowEarnings below estimates

    Q2-2026: EPS $-0.43 vs $-0.0136 estimate, -0.42 on a near-zero consensus

  • mediumEarnings below estimates

    Q1-2027: Missed consensus by 55.8%, EPS $-0.32 vs $-0.2054 estimate

  • mediumEarnings below estimates

    Q3-2026: Missed consensus by 55.8%, EPS $-0.32 vs $-0.2054 estimate

  • mediumEarnings below estimates

    Q1-2027: Missed consensus by 64.3%, EPS $-0.32 vs $-0.1948 estimate

FREE, NO ACCOUNT

Every event on TLRY, as it fires

You are seeing 5 of 14 events recorded on TLRY since 2026-05-29.

The five above landed across 3 days. The other 9 were recorded on 4 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, TLRY

More data on TLRY

TLRY against its peers

TLRY's operating margin of -6.9% ranks in the 58th percentile of 17 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-05-31.

MetricTLRYPeer medianPercentilen
Revenue FY915M USD181M USD9716
Gross margin28.4%50.3%1417
Operating margin-6.9%-11.0%5817
Net margin-13.3%-20.6%6917
Return on equity-7.5%-25.1%7215
1 year-75.6%-31.7%1319

Peers (19): VREOF, VRNO, NIKA, ELTP, EOLS, KMDA, AQST, TKNO, CGC, CRLBF, ADCT, AKBA, CRDL, DERM, HROW, GLAS, TSNDF, BGM, CRON. Left out: BORAY (no annual filing), LFCR (no annual filing), EVO (period gap), ASRT.D (no annual filing), PHBI (period gap), OGI (period gap). Fiscal periods ending between 2025-09-30 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (TLRY: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in TLRY on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on TLRY in the last 180 days.

Upstream: SEC EDGAR filings for TLRY

Kresmion, "Tilray Brands, Inc. (TLRY) institutional holdings and SEC filings", data as of 2026-10-26, https://kresmion.com/research/TLRY. Upstream data: SEC EDGAR filings for TLRY.

Link to this data (HTML):

<a href="https://kresmion.com/research/TLRY">Tilray Brands, Inc. (TLRY) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow TLRY on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to TLRY for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the TLRY dossier
Share

The TLRY intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.